The implementation of drug reposition for alcoholic hepatitis based on a sub-pathway integration strategy

BACKGROUND: Alcoholic hepatitis (AH) is one of the most severe forms of liver disease. The therapies which are currently available are not entirely effective, and thus novel therapies are urgently needed. However, the development of these novel therapies is limited due to incomplete information abou...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Wei, Wang, Bing, Yang, Ming, Zhu, Lin, Hu, Sen, Sun, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154418/
https://www.ncbi.nlm.nih.gov/pubmed/32309355
http://dx.doi.org/10.21037/atm.2020.01.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154418/
https://www.ncbi.nlm.nih.gov/pubmed/32309355
http://dx.doi.org/10.21037/atm.2020.01.36

Ejemplares similares